Cargando…
Differential expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma: Retrospective study
Peripheral T-cell lymphoma is a disease that includes multiple T-cell lymphoma subtypes. It is still unclear whether CD30 can be used as a new target molecule and classification standard for PTCL. Differences in the molecular characteristics of CD30-positive PTCL and CD30-negative PTCL have rarely b...
Autores principales: | Wang, Yajing, Zhang, Fei, Gao, Ning, Bu, Peng, Cui, Wei, Xi, Yanfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10659667/ https://www.ncbi.nlm.nih.gov/pubmed/37986346 http://dx.doi.org/10.1097/MD.0000000000035531 |
Ejemplares similares
-
Impact of Single or Combined Genomic Alterations of TP53, MYC, and BCL2 on Survival of Patients With Diffuse Large B-Cell Lymphomas: A Retrospective Cohort Study
por: Schiefer, Ana-Iris, et al.
Publicado: (2015) -
Immunohistochemical overexpression of BCL-2 protein predicts an inferior survival in patients with primary central nervous system diffuse large B-cell lymphoma
por: Chen, Yi, et al.
Publicado: (2019) -
Peripheral T cell lymphoma coexisting with Castleman's disease: A case report and literature review
por: Liu, Shuyan, et al.
Publicado: (2020) -
Expression of PD-1/PD-L1 in peripheral blood and tumor tissues of patients with classical Hodgkin’s lymphoma
por: Feng, Xia, et al.
Publicado: (2023) -
A case report of nodal CD4-positive T-cell lymphoproliferative disorder with an indolent course
por: Ge, Xiaowen, et al.
Publicado: (2018)